istopmm study – the impact of nationwide screening
Published 2 years ago • 56 plays • Length 0:44Download video MP4
Download video MP3
Similar videos
-
5:11
istopmm: the psychological effects of mgus screening and changes to clinical presentation of myeloma
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
3:11
the therapeutic implications of shared pathophysiology in classical itp and other thrombocytopenias
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:08
real-world analysis of the most study: factors impacting progression to mf in patients with et
-
2:00
the incorporation of immunotherapy into frontline all treatment
-
5:13
what is a haematologist?
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
3:08
the treatment protocol for higher risk mds
-
0:52
is there a role for combination therapy in cml?
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
1:59
a subgroup analysis of majestec-1: teclistamab in multiple myeloma with high-risk features
-
2:49
an insight into the mmrf-commpass study
-
1:16
state of the art: mds
-
2:09
heart transplantation in attr amyloidosis
-
3:28
molecular prognostication in smm
-
2:04
state-of-the-art treatment for hr-mds
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:59
session overview: pitfalls in the diagnosis of bleeding disorders & research networks in the uk